NO973293L - Grönne porfyriner som immunmodulatorer - Google Patents

Grönne porfyriner som immunmodulatorer

Info

Publication number
NO973293L
NO973293L NO973293A NO973293A NO973293L NO 973293 L NO973293 L NO 973293L NO 973293 A NO973293 A NO 973293A NO 973293 A NO973293 A NO 973293A NO 973293 L NO973293 L NO 973293L
Authority
NO
Norway
Prior art keywords
immune modulators
green porphyrins
green
antigen
porphyrins
Prior art date
Application number
NO973293A
Other languages
English (en)
Norwegian (no)
Other versions
NO973293D0 (no
Inventor
Agnes H Chan
David W C Hunt
Julia G Levy
Modestus O K Obochi
Anna M Richter
Guillermo O Simkin
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of NO973293D0 publication Critical patent/NO973293D0/no
Publication of NO973293L publication Critical patent/NO973293L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F132/00—Homopolymers of cyclic compounds containing no unsaturated aliphatic radicals in a side chain, and having one or more carbon-to-carbon double bonds in a carbocyclic ring system
    • C08F132/08—Homopolymers of cyclic compounds containing no unsaturated aliphatic radicals in a side chain, and having one or more carbon-to-carbon double bonds in a carbocyclic ring system having condensed rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
NO973293A 1995-01-17 1997-07-16 Grönne porfyriner som immunmodulatorer NO973293L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/374,158 US5789433A (en) 1995-01-17 1995-01-17 Green porphyrins as immunomodulators
PCT/CA1996/000020 WO1996022090A1 (en) 1995-01-17 1996-01-11 Green porphyrins as immunomodulators

Publications (2)

Publication Number Publication Date
NO973293D0 NO973293D0 (no) 1997-07-16
NO973293L true NO973293L (no) 1997-09-16

Family

ID=23475554

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973293A NO973293L (no) 1995-01-17 1997-07-16 Grönne porfyriner som immunmodulatorer

Country Status (13)

Country Link
US (2) US5789433A (cs)
EP (1) EP0794775A1 (cs)
KR (1) KR100332554B1 (cs)
CN (1) CN1198671A (cs)
AU (1) AU706796B2 (cs)
CZ (1) CZ291179B6 (cs)
FI (1) FI972952L (cs)
HU (1) HUP9801528A3 (cs)
NO (1) NO973293L (cs)
NZ (1) NZ298356A (cs)
PL (1) PL321362A1 (cs)
TW (1) TW384222B (cs)
WO (1) WO1996022090A1 (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107325A (en) * 1995-01-17 2000-08-22 Qlt Phototherapeutics, Inc. Green porphyrins as immunomodulators
US6096776A (en) * 1995-01-17 2000-08-01 Qlt Phototherapeutics, Inc. Green porphyrins as immunomodulators
US5789433A (en) * 1995-01-17 1998-08-04 Quadra Logic Technologies, Inc. Green porphyrins as immunomodulators
US5834503A (en) * 1996-06-14 1998-11-10 Qlt Phototherapeutics, Inc. Methods to treat arterial plaque
AU7422098A (en) * 1997-05-16 1998-12-11 Qlt Phototherapeutics, Inc. Green porphyrins as immunomodulators
CA2221912A1 (en) * 1997-11-21 1999-05-21 David Dolphin Photosensitizers with improved biodistribution and light-absorbing properties
US6428579B1 (en) * 1998-07-01 2002-08-06 Brown University Research Foundation Implantable prosthetic devices coated with bioactive molecules
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
WO2002064163A2 (en) 2001-02-15 2002-08-22 Qlt Inc. Reduction or prevention of pdt related inflammation
AU2002348477A1 (en) * 2001-05-01 2002-12-23 The General Hospital Corporation Photoimmunotherapies for cancer using photosensitizer immunoconjugates and combination therapies
DE60219627T2 (de) 2001-06-04 2008-02-07 The General Hospital Corp., Boston Nachweis und therapie von empfindlichem plaque mit photodynamischen verbindungen
US7220778B2 (en) * 2003-04-15 2007-05-22 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
US7659301B2 (en) * 2003-04-15 2010-02-09 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
WO2004099375A2 (en) * 2003-04-30 2004-11-18 The General Hospital Corporation Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use therof
US20040220167A1 (en) * 2003-05-02 2004-11-04 Nasrollah Samiy Methods of treating neuralgic pain
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
ES2454974T3 (es) 2007-06-27 2014-04-14 The General Hospital Corporation Aparato para la inhibición óptica de la terapia fotodinámica
KR101595138B1 (ko) * 2008-02-27 2016-02-18 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 괴사종양의 광역학요법 및 영상용 알지디(박테리오)클로로필 컨쥬게이트
US7968127B2 (en) * 2008-07-28 2011-06-28 Winslow David E Reverse vitamin K effect via photodynamic oxidation targeted at vascular endothelium, fibrin and blood platelets
US8709400B2 (en) * 2009-07-27 2014-04-29 Washington University Inducement of organogenetic tolerance for pancreatic xenotransplant
CN103127500B (zh) * 2013-02-07 2015-05-20 中山大学 卟啉色素作为免疫佐剂和疫苗的用途
CN110201162B (zh) * 2019-06-14 2021-09-07 中山大学附属第八医院（深圳福田） 光治疗剂在打破肿瘤免疫抑制微环境中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US4838852A (en) * 1987-03-27 1989-06-13 Therakos, Inc. Active specific immune suppression
US5087636A (en) * 1990-02-20 1992-02-11 University Of British Columbia Method to destroy malignant cells in mononuclear cell populations
FR2689888B1 (fr) * 1992-04-10 1994-06-10 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5422362A (en) * 1993-07-29 1995-06-06 Quadra Logic Technologies, Inc. Method to inhibit restenosis
ES2227578T3 (es) * 1995-01-13 2005-04-01 University Of British Columbia Procedimiento para prevenir el rechazo de transplantes.
US5789433A (en) * 1995-01-17 1998-08-04 Quadra Logic Technologies, Inc. Green porphyrins as immunomodulators
CA2231114A1 (en) * 1995-09-06 1997-03-13 The Research Foundation Of State University Of New York Two-photon upconverting dyes and applications

Also Published As

Publication number Publication date
FI972952A7 (fi) 1997-09-10
JP3574456B2 (ja) 2004-10-06
PL321362A1 (en) 1997-12-08
AU4381996A (en) 1996-08-07
EP0794775A1 (en) 1997-09-17
US6008241A (en) 1999-12-28
NO973293D0 (no) 1997-07-16
TW384222B (en) 2000-03-11
HUP9801528A2 (hu) 1998-10-28
MX9705376A (es) 1997-10-31
NZ298356A (en) 2001-04-27
CN1198671A (zh) 1998-11-11
CZ221397A3 (en) 1997-11-12
AU706796B2 (en) 1999-06-24
KR19980701484A (ko) 1998-05-15
FI972952L (fi) 1997-09-10
HUP9801528A3 (en) 2000-02-28
US5789433A (en) 1998-08-04
JPH10512268A (ja) 1998-11-24
FI972952A0 (fi) 1997-07-11
WO1996022090A1 (en) 1996-07-25
CZ291179B6 (cs) 2003-01-15
KR100332554B1 (ko) 2002-09-27

Similar Documents

Publication Publication Date Title
NO973293L (no) Grönne porfyriner som immunmodulatorer
EA199800946A1 (ru) Концентрированный препарат антител
TW373404B (en) Light source for projection display
ATE405243T1 (de) Säuglingspflegevorrichtung
EA200500206A1 (ru) СПОСОБ И КОМПОЗИЦИИ ДЛЯ МОДУЛЯЦИИ РАЗВИТИЯ И ФУНКЦИИ КЛЕТОК Т-ХЕЛПЕРОВ (Тх)
IL138034A0 (en) Apo-2 ligand-anti-her-2 antibody synergism
DK0658118T3 (da) Vaccine mod Neisseria meningitidis, gruppe C
DE69317282D1 (de) Anti-Rezeptor Antikörper gegen den Vitamin B12/transcobalamin II Rezeptor
NZ336196A (en) Use of green porphyrins for the treatment of secondary cataracts
WO2002050631A3 (en) A method and system for authorizing generation of asymmetric crypto-keys
IE820084L (en) Azabicyclohexanones.
ATE183385T1 (de) Lyopilisierte, wirkstoffhaltige emulsion
NO904484D0 (no) Anordning til fastholding av seismiske innretninger, saerlig seismiske energikilder.
DK159590D0 (da) To-trins-reduktionsventil, fortrinsvis til gasflasker
NO913019D0 (no) Faste orale preparatformer som inneholder ifosfamid som virksomt stoff.
AU550941B2 (en) Portable foldable invalid walker seat
CA2210152A1 (en) Green porphyrins as immunomodulators
AU580157B2 (en) Pantethine component for hair permanent waving
BG101526A (en) Antiphlogistic composition for external application
DE69534818D1 (de) Wachstumsinhibierende agenzien gegen vitamin b12 bindungsstellen von transcobalamin-ii
DK0653932T3 (da) Midler til bruning af huden
McGraw The ZZ Ceti Stars-a New Class of Pulsating White Dwarfs.
Andronov On the luminosity dependence of the light curve of AM Herculis.
Pensado Differential UBV photometry of SW Lacertae.
Malkan The Ionizing Flux from Star-Forming Galaxies

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application